TACSTD2 and breast carcinoma: Extension of the study to HCC1500 and MDA-MD-453, two other breast cancer lines with very different characteristics, showed similar differential localization and antagonistic LOF phenotypes, suggesting that these are general properties of the EpCAM/Trop2 pair.